Download Files:
Garsorasib
$395 – $2,960
Products Details
Product Description
– Garsorasib is a potent inhibitor of KRAS G12C with an IC50 of 10 nM. Garsorasib has the potential for the research of various cancer such as pancreatic cancer, endometrial cancer, colorectal cancer, or lung cancer (non-small cell lung cancer) (extracted from patent WO2020233592A1, compound 2)[1].
Web ID
– HY-145571
Storage Temperature
– 4°C (Powder, stored under nitrogen)
Shipping
– Room Temperature
Applications
– Cancer-Kinase/protease
Molecular Formula
– C32H32F2N8O2
References
– [1]Wang, Lisha, et al. Cbp/ep300 inhibitor and use thereof. Patent WO2021213521A1.
CAS Number
– 2559761-14-5
Molecular Weight
– 598.65
Compound Purity
– 99.11
SMILES
– O=C1N(C2=NC(C3=C(C=CC=C3N)F)=C(F)C=C2C(N4[C@H](CN([C@@H](C4)C)C(C=C)=O)C)=N1)C5=C(C6CC6)N=CN=C5C7CC7
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– DMSO : 100 mg/mL (ultrasonic)
Target
– Ras
Isoform
– K-Ras
Pathway
– GPCR/G Protein
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
